Join our community of smart investors

Oxford Instruments still trying to shake off Covid

First-half sales disrupted by lockdowns in China and supply chain stresses
November 8, 2022
  • Order book grows by 29 per cent to £316mn
  • Operating profit up 21 per cent to £26.3mn

For many businesses, Covid-related disruptions are already a thing of the past.

For Oxford Instruments (OXIG), though, an inability to access customer sites in China held back growth, as did a requirement to secure more export licenses to ship products to the country – some of which were refused. 

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in